• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Fred Hutchinson Cancer Research Center

Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Vir looks to Liu to lead late-stage push—Chutes & Ladders

Vir looks to Liu to lead late-stage push. Cerevance strengthens C-suite. Biogen alum preps ProMIS’s budding Alzheimer’s program.
Darren Incorvaia , Marissa Russo , Donavyn Coffey Oct 9, 2026 8:30am
Seattle

Paul Allen research foundation unveils with $500M funding plan

Aug 27, 2025 11:59am
visual of gut bacteria

Mouth microbe on the move may drive colorectal cancer

Mar 25, 2024 3:30pm
Cancer cells

Affini-T banks $175M to enter crowded KRAS-cancer field

Mar 22, 2022 7:30am
Cincinnati

Treating leukemia by targeting tumor 'seeds,' 'essential genes'

Mar 15, 2022 8:59am
Fred Hutch

TCR-T cells fend off evasive leukemia, solid tumors in mice

Feb 9, 2022 2:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings